Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.40 |
| ▸ | GPR3 | P46089 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | KIF11 | P52732 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | CASR | P41180 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | TNF | P01375 | 1/20 | 0.31 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.30 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.30 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.30 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2388003 | 0.87 | GPR3 (0.56) | CA2GABRA1GABRB2GPR3ALDH1A1 | |
| SCHEMBL21972234 | 0.84 | LIMK1 (0.41) | CA2GPR3ALDH1A1TSHRTDP1 | |
| SCHEMBL23051359 | 0.82 | GPR3 (0.41) | CA2GPR3ALDH1A1TSHRTDP1 | |
| SCHEMBL23621472 | 0.81 | CA2 (0.39) | CA2GABRA1GABRB2GPR3ALDH1A1 | |
| SCHEMBL24311312 | 0.80 | RXRB (0.36) | CA2KIF11TNFNOD1ALOX5 | |
| SCHEMBL16243459 | 0.80 | MAPT (0.50) | GPR3ALDH1A1TDP1KIF11NPSR1 | |
| SCHEMBL25643390 | 0.80 | APEX1 (0.37) | CA2GABRA1GABRB2GPR3ALDH1A1 | |
| SCHEMBL25490448 | 0.80 | BCL2L1 (0.36) | CA2GABRA1GABRB2GPR3ALDH1A1 | |
| SCHEMBL25456442 | 0.79 | SLC9A1 (0.41) | ALDH1A1TSHRNPSR1 | |
| SCHEMBL23051201 | 0.78 | GPR3 (0.36) | CA2GPR3ALDH1A1TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11778901-B2 | Organic electroluminescent material and organic electroluminescent device comprising same | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-10-03 | — | — | US | disclosed |
| US-20230242484-A1 | NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC APPARATUS USING SAME | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-08-03 | — | — | US | disclosed |
| US-20230200232-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT COMPRISING SAME, AND ELECTRONIC APPARATUS | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-06-22 | — | — | US | disclosed |
| US-20230146030-A1 | ARYLAMINE COMPOUND, ELECTRONIC COMPONENT USING SAME AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-05-11 | — | — | US | disclosed |
| US-20220416164-A1 | NITROGEN-CONTAINING COMPOUNDS, ELECTRONIC ELEMENTS AND ELECTRONIC DEVICES | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242484-A1 | NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC APPARATUS USING SAME | MNS1, NSFL1C, NCF1 | CA2 2310/4885GABRA1 4157/4885GABRB2 4436/4885 |
| US-20230200232-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT COMPRISING SAME, AND ELECTRONIC APPARATUS | EXOSC10, NUDC, NSFL1C | CA2 3096/4885GABRA1 4621/4885GABRB2 4554/4885 |
| US-20230146030-A1 | ARYLAMINE COMPOUND, ELECTRONIC COMPONENT USING SAME AND ELECTRONIC DEVICE | OCIAD2, AOC2, OCIAD1 | CA2 4752/4885GABRA1 4726/4885GABRB2 4648/4885 |
| US-11778901-B2 | Organic electroluminescent material and organic electroluminescent device comprising same | MAOA, AOC1, AOC2 | CA2 4370/4885GABRA1 2574/4885GABRB2 3170/4885 |
| US-20220416164-A1 | NITROGEN-CONTAINING COMPOUNDS, ELECTRONIC ELEMENTS AND ELECTRONIC DEVICES | NPPA, NES, INA | CA2 1274/4885GABRA1 4458/4885GABRB2 4169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.